tiprankstipranks
Theriva Biologics (DE:SFY)
FRANKFURT:SFY

Theriva Biologics (SFY) Technical Analysis

4 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
2Bullish
5Neutral
15Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Theriva Biologics’s (SFY) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Theriva Biologics is a Sell.
Theriva Biologics’s (SFY) 20-Day exponential moving average is 0.41, while Theriva Biologics’s (SFY) share price is €0.406, making it a Sell.
Theriva Biologics’s (SFY) 50-Day exponential moving average is 0.42, while Theriva Biologics’s (SFY) share price is €0.406, making it a Sell.

Theriva Biologics (SFY) Pivot Points

May 05, 2024, 01:58 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.42
0.42
0.42
0.42
0.42
0.42
0.42
Fibonacci
0.42
0.42
0.42
0.42
0.42
0.42
0.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Theriva Biologics (SFY) Moving Averages

May 05, 2024, 01:58 AM
Period
Simple
Exponential
MA5
0.43Sell
0.42Sell
MA10
0.41Sell
0.42Sell
MA20
0.41Sell
0.41Sell
MA50
0.41Sell
0.42Sell
MA100
0.43Sell
0.43Sell
MA200
0.48Sell
0.49Sell
Theriva Biologics’s (SFY) 10-Day exponential moving average is 0.42, while Theriva Biologics’s (SFY) share price is €0.406, making it a Sell.
Theriva Biologics’s (SFY) 100-Day exponential moving average is 0.43, while Theriva Biologics’s (SFY) share price is €0.406, making it a Sell.
Theriva Biologics’s (SFY) stock price is €0.406 and Theriva Biologics’s (SFY) 50-day simple moving average is 0.41, creating a Sell signal.
Theriva Biologics’s (SFY) stock price is €0.406 and Theriva Biologics’s (SFY) 100-day simple moving average is 0.43, creating a Sell signal.
Theriva Biologics’s (SFY) stock price is €0.406 and Theriva Biologics’s (SFY) 200-day simple moving average is 0.48, creating a Sell signal.

Theriva Biologics (SFY) Technical Indicators

May 05, 2024, 01:58 AM
Name
Value
Implied Action
RSI (14)
47.26
Neutral
STOCH (9,6)
70.54
Neutral
STOCHRSI (14)
70.54
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
9.89
Buy
Williams %R
-53.49
Buy
CCI (14)
-31.45
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
56.11
Neutral
ROC
-3.81
Sell
Theriva Biologics’s (SFY) Relative Strength Index (RSI) is 47.26, creating a Neutral signal.
Theriva Biologics’s (SFY) Trend Strength Indicator (ADX) is 9.89, creating a Buy signal.
Theriva Biologics’s (SFY) Commodity Channel Index (CCI) is -31.45, creating a Neutral signal.
Theriva Biologics’s (SFY) Price Rate of Change (ROC) is -3.81, creating a Sell signal.

FAQ

Is SFY a Buy, Hold, or Sell?
Based on SFY’s technical indicators, SFY is a Strong Sell.
    What is SFY’s RSI (14)?
    SFY’s RSI (14) is 47.26, which suggests SFY is a Neutral.
      What is SFY’s MACD?
      SFY’s MACD is <0.01, which suggests SFY is a Sell.
        What is SFY’s 5-day moving average?
        SFY’s 5-day moving average is 0.43, which suggests SFY is a Sell.
          What is SFY’s 20-day moving average?
          SFY 20-day moving average is 0.41, which suggests SFY is a Sell.
            What is SFY’s 50-day moving average?
            SFY’s 50-day moving average is 0.41, which suggests SFY is a Sell.
              What is SFY’s 200-day moving average?
              SFY’s 200-day moving average is 0.48, which suggests SFY is a Sell.
                What is SFY’s Williams % R (14)?
                SFY’s Williams % R (14) is -53.49, which suggests SFY is a Buy.
                  What is SFY’s CCI (14)?
                  SFY’s CCI (14) is -31.45, which suggests SFY is a Neutral.
                    What is the share price of Theriva Biologics?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis